Manuela Callari shares the astounding lack of knowledge regarding the drugs used in assisted suicide. This level of uncertainty and concealment would not be tolerated in any other medical field or circumstance. This troubling article reveals just how experiential assisted suicide drugs are.

Lisa Beaudoin, of Strategies for Disability Equity, writes, "To ignore or leapfrog over the needs of health disparity populations — who struggle to obtain basic care and who are simultaneously put at further risk by physician-assisted suicide laws — is yet another unconscionable example of how people already able to access good care get yet more options while vulnerable populations continue to wait for public health policies to address their needs."

"Deciding to end one’s life, an absolute and irrevocable act, cannot be treated as a purely rational and dispassionate decision or one free from influence or coercion. By treating suicide as 'normal' for certain groups (i.e. the disabled or seriously ill), but as a crisis for others, we set up a glaring contradiction," writes Shannon McGinley, Executive Director of Cornerstone Action and Cornerstone Policy Research.

"There is nothing to be gained from a bad bill, certainly not one that legislates on life and death. Some MPs scrutinising the bill appear to believe their primary duty is to support Ms Leadbeater, rather than scrutinising and improving her proposals. The results are there to see. Ms Leadbeater’s decision to drop High Court approval for each case of assisted dying — replacing the judge with an “expert” panel — weakens a critical safeguard."

PRAF is a leading national, non-partisan single-issue organization that protects the rights of patients, people with disabilities, older adults, and other historically underrepresented groups from deadly harm and discrimination inherent in assisted suicide laws.

954 Lexington Ave, #340

New York, NY 10021

(609) 759-0322